Sarcopenia: Definition, measurement methods, therapeutic future;La sarcopénie: Définition, méthodes de mesure, avenir thérapeutique

Revue Medicale Suisse

Volumn 7, Issue 294, 2011, Pages 1047-1048

  Rivier, Etienne ^a   Krieg, Marc Antoine ^b   Lamy, Olivier ^b  

^a Hopital Riviera   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; HUMAN; MUSCLE ATROPHY; SHORT SURVEY; TREATMENT FAILURE;

AGED; ELECTRIC IMPEDANCE; HUMANS; MUSCLE STRENGTH DYNAMOMETER; SARCOPENIA;

EID: 79957596642     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Rolland Y, Vellas B. La sarcopénie. Rev Med Interne 2009;30:150-60.
2. Lynch GS, Schertzer JD, Ryall JG. Therapeutic approaches for muscule wasting disorders. Pharmacol Ther 2007;113:461-87. (Pubitemid 46365957)
3. Bautmans I, Van Puyvelde K, Mets T. Sarcopenia and functional decline: Pathophysiology, prevention and therapy. Acta Clinica Belgia 2009;64:303-16.
4. Cruz-Jentoft AJ, Bayens JP, Bauer JM, et al. Sarcopenia European consensus on definition and diagonosis. Age Ageing 2010;39:412-23.
5. Thomas DR. Sarcopenia. Clin Geriatr Med 2010;26: 331-46.